1. Is Take Solutions Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Take Solutions Ltd is a below average quality company.
2. Is Take Solutions Ltd undervalued or overvalued?
The key valuation ratios of Take Solutions Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Take Solutions Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Take Solutions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||11.7%||12.1%||5.9%||1.9%||2.5%||1.1%||0.9%||0.9%||0.4%||0.1%||-|
|Value Creation Index ⓘ||-0.2||-0.1||-0.6||-0.9||-0.8||-0.9||-0.9||-0.9||-1.0||-1.0||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||-23.2%||-11.9%||-0.5%||-9%||-20.1%||-87.1%||800%||-88.8%||-24.7%||-|
|Adj EPS ⓘ||2.9||3.1||1.4||0.5||0.7||0.2||0.3||0.5||0.2||0.1||-0.4|
|YoY Gr. Rt. %||-||4.5%||-53.1%||-64.3%||37.3%||-67.1%||43.5%||36.4%||-62.2%||-70.6%||-|
|BVPS (₹) ⓘ||24.3||26.4||26.7||26.4||26.5||38.3||51.5||50.9||51||51.7||20.2|
|Adj Net Profit ⓘ||35.1||36.6||17.1||6.1||8.4||3||4.8||6.7||2.5||0.8||-5|
|Cash Flow from Ops. ⓘ||142||0||0||-2.6||-10.8||-33||-24||12.9||-14.9||-2.7||-|
|Debt/CF from Ops. ⓘ||0.3||0||0||0||-6.8||0||0||0||0||0||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||-36.4%||-41%||-46.7%||-70.6%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||12.5||12||5.4||1.9||2.6||0.7||0.8||0.9||0.3||0.1||-1|
|Op. Profit Mgn % ⓘ||25.2||19.7||13.8||5.6||22.1||-16.7||-664.4||-63.2||-685.8||-713.1||-35.3|
|Net Profit Mgn % ⓘ||91.3||124.2||65.8||23.4||35.6||16.2||197.2||30.3||101.7||40.6||-17|
|Debt to Equity ⓘ||0.2||0||0||0||0.2||0||0||0||0||0||0|
|Working Cap Days ⓘ||1,414||1,009||822||625||789||1,936||26,120||3,642||35,731||49,131||2,285|
|Cash Conv. Cycle ⓘ||20||38||-29||-179||-130||-17||272||34||979||855||2,184|
Sales growth is good in last 4 quarters at 1306.09%
Return on Equity is Poor
Sales growth has been subdued in last 3 years 0.00%
|TTM EPS (₹)||-0.4||-52.9|
|TTM Sales (₹ Cr.)||30.4||655|
|BVPS (₹.) ⓘ||20.2||12.3|
|Reserves (₹ Cr.) ⓘ||284||166|
|From the Market|
|52 Week Low / High (₹)||20.65 / 62.00|
|All Time Low / High (₹)||4.70 / 308.30|
|Market Cap (₹ Cr.)||397|
|Equity (₹ Cr.)||14.8|
|Face Value (₹)||1|
|Industry PE ⓘ||29.8|
TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange.
Business area of the company
The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.
Products and services
Supply Chain Management:
Company’s technology products and solutions are: